Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Polish Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabkin, J. G.
Right arrow Articles by Mitsumoto, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabkin, J. G.
Right arrow Articles by Mitsumoto, H.
NEUROLOGY 2005;65:62-67
© 2005 American Academy of Neurology

Prevalence of depressive disorders and change over time in late-stage ALS

J. G. Rabkin, PhD, MPH, S. M. Albert, PhD, M. L. Del Bene, MS, NP-P, I. O'Sullivan, MS, NP-P, T. Tider, MSW, L. P. Rowland, MD and H. Mitsumoto, MD

From the New York State Psychiatric Institute, New York, NY.

Address correspondence and reprint requests to Dr. J. Rabkin, New York State Psychiatric Institute, 1051 Riverside Dr., New York, NY 10032; e-mail: jgr1{at}Columbia.edu

Objective: To determine the prevalence of depressive disorders and symptoms in patients with late-stage ALS, to identify possible risk and protective factors associated with depression, and to determine whether depression increases as death approaches.

Methods: Semistructured interviews were conducted monthly with hospice-eligible patients with ALS and caregivers until the study endpoints of death or tracheostomy. Standardized measures were administered to assess depressive disorders and symptoms, hopelessness, spiritual beliefs, attitudes toward hastened death, quality of life, and related constructs.

Results: Sixty-three percent of eligible patients were enrolled. Of the 80 participants, 17 were seen only once; the number of monthly assessments for the others ranged from 2 to 18. For the 53 patients who died, median interval between last assessment and death was 30 days. At study baseline, 81% had no depressive disorder, 10% had minor depression, and 9% had symptoms consistent with major depression. Diagnoses of depression were made on 16% of 369 monthly assessments. Fifty-seven percent of patients never had a depression diagnosis at any visit, and 8% were depressed at all visits. There was no trend toward increasing depression as death approached. Presumed protective factors including spiritual beliefs, spouse as care partner, financial situation, depression in caregiver, and hospice participation did not distinguish between those who were depressed and those who were not.

Conclusions: Results of multiple measures of depression and distress converged to indicate that major depression in people with late-stage ALS is rare, although transient depressive symptoms may occur, and depression does not generally increase as death approaches.


Commentary, see page 1

Editorial, see page 9

See also page 68

Received December 21, 2004. Accepted in final form March 4, 2005.


Related articles in Neurology:

July 12 Highlights and Commentary: ALS, depression, and desire for a hastened death: (How) are they related?

Neurology 2005 65: 1. [Full Text]  

Wish to die in end-stage ALS
S. M. Albert, J. G. Rabkin, M. L. Del Bene, T. Tider, I. O'Sullivan, L. P. Rowland, and H. Mitsumoto
Neurology 2005 65: 68-74. [Abstract] [Full Text]  

Exit strategies in ALS: An influence of depression or despair?
Richard K. Olney and Catherine Lomen-Hoerth
Neurology 2005 65: 9-10. [Full Text]  



This article has been cited by other articles:


Home page
NeurologyHome page
H. Schmolck, D. Mosnik, and P. Schulz
Rating the approachability of faces in ALS
Neurology, December 11, 2007; 69(24): 2232 - 2235.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. Mitsumoto and J. G. Rabkin
Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best"
JAMA, July 11, 2007; 298(2): 207 - 216.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Gourie-Devi and S. M. Albert
Wish to die in end-stage ALS
Neurology, January 2, 2007; 68(1): 79 - 79.
[Full Text] [PDF]


Home page
NeurologyHome page
L. H. Goldstein, L. Atkins, S. Landau, R. G. Brown, and P. N. Leigh
Longitudinal predictors of psychological distress and self-esteem in people with ALS.
Neurology, November 14, 2006; 67(9): 1652 - 1658.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. K. Olney and C. Lomen-Hoerth
Exit strategies in ALS: An influence of depression or despair?
Neurology, July 12, 2005; 65(1): 9 - 10.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.